These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 359486)

  • 21. Comparison of CA 19-9 and carcinoembryonic antigen (CEA) levels in the serum of patients with colorectal diseases.
    Kuusela P; Jalanko H; Roberts P; Sipponen P; Mecklin JP; Pitkänen R; Mäkelä O
    Br J Cancer; 1984 Feb; 49(2):135-9. PubMed ID: 6582896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Using CEA for diagnostic, therapeutic and prognostic evaluation in colorectal cancers].
    Terabe K; Ichihashi H; Kamei H; Kondo T
    Gan To Kagaku Ryoho; 1984 Jan; 11(1):111-6. PubMed ID: 6696454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evaluation of combined CA-19-9 and CEA assay in monitoring recurrences and metastases of colorectal cancer].
    Yu BM
    Zhonghua Wai Ke Za Zhi; 1992 Dec; 30(12):707-9, 777. PubMed ID: 1339738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carcinoembryonic antigen: usefulness as a postsurgical method in the detection of recurrence in Dukes stages B2 and C colorectal cancers.
    Koch M; Washer G; Gaedke H; McPherson TA
    J Natl Cancer Inst; 1982 Oct; 69(4):813-5. PubMed ID: 6956758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leukocyte adherence inhibition (LAI) test, LAI. Trypsin and LAI. Humoral test in large term immunotherapy with levamisole on breast and colon cancer.
    De Carli HO; Restbergs V
    Rev Esp Oncol; 1983; 30(1):25-39. PubMed ID: 6387830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation of the Serum Level of Carcinoembryonic Antigen and Prolactin with Different Stages of Colorectal Carcinoma According to Dukes' Staging.
    Rahman MR; Sheikh SH; Lima IJ; Islam MR; Faisal M; Islam MS; Faruk MO; Jalal MT
    Mymensingh Med J; 2016 Jan; 25(1):61-5. PubMed ID: 26931251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between the results of carcinoembryonal antigen (CEA) test and the clinical stage of colorectal carcinoma.
    Molnár L; Rahóty P; Bauer E; Rónay P; Besznyák I; Ottó S
    Acta Chir Hung; 1986; 27(1):27-34. PubMed ID: 3716715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Use of the leukocyte adherence inhibition test in rectocolonic cancers].
    Bara J; Poupon MF
    Gastroenterol Clin Biol; 1984 Oct; 8(10):733-5. PubMed ID: 6396146
    [No Abstract]   [Full Text] [Related]  

  • 29. CEA tissue staining in colorectal cancer patients. A way to improve the usefulness of serial serum CEA evaluation.
    Midiri G; Amanti C; Benedetti M; Campisi C; Santeusanio G; Castagna G; Peronace L; Di Tondo U; Di Paola M; Pascal RR
    Cancer; 1985 Jun; 55(11):2624-9. PubMed ID: 2986820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Automated leucocyte adherence inhibition testing in patients with colorectal cancer.
    McLeod DK; Isbister WH
    Immunol Cell Biol; 1987 Oct; 65 Pt 5():377-85. PubMed ID: 3325409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carcinoembryonic antigen in patients with colorectal cancer: correlation between stage of disease and antigen level.
    Bartal AH; Ayalon D; Cordova T; Avidan S; Robinson E
    Isr J Med Sci; 1983 Sep; 19(9):801-5. PubMed ID: 6643017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monitoring of colon cancer through measurement of carcinoembroyonic antigen levels, tests of cellular immune competence, and tumor specific immunity.
    Holyoke ED; Goldrosen MH
    Int Adv Surg Oncol; 1978; 1():85-111. PubMed ID: 399765
    [No Abstract]   [Full Text] [Related]  

  • 33. CEA radioimmunoassay. Clinical applications in colorectal cancer.
    Huyghe J
    Acta Chir Belg; 1983; 83(2):77-88. PubMed ID: 6858539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of CEA as an indicator of early recurrence and as a guide to a selected second-look procedure in patients with colorectal cancer.
    Wanebo JH; Stearns M; Schwartz MK
    Ann Surg; 1978 Oct; 188(4):481-93. PubMed ID: 697433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Carcinoembryonic antigen, CEA, in colorectal cancer. An insensitive marker which may be excluded from follow-ups].
    Wählby L
    Lakartidningen; 1997 Apr; 94(18):1716-8. PubMed ID: 9182180
    [No Abstract]   [Full Text] [Related]  

  • 36. Leukocyte adherence inhibition in patients with nonmalignant disorders of the colon and colorectal cancer.
    Tank B; Marquet RL; Vennemans E; Westbroek DL
    J Cancer Res Clin Oncol; 1986; 112(3):276-80. PubMed ID: 3782265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A study of the reliability of carcinoembryonic antigen blood levels in following the course of colorectal cancer.
    Armitage NC; Davidson A; Tsikos D; Wood CB
    Clin Oncol; 1984 Jun; 10(2):141-7. PubMed ID: 6375928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of carcinoembryonic antigen levels between portal and peripheral blood in patients with colorectal cancer. Correlation with histopathologic variables.
    Tabuchi Y; Deguchi H; Imanishi K; Saitoh Y
    Cancer; 1987 Apr; 59(7):1283-8. PubMed ID: 3815304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and immune responses in resected colon cancer patients treated with anti-idiotype monoclonal antibody vaccine that mimics the carcinoembryonic antigen.
    Foon KA; John WJ; Chakraborty M; Das R; Teitelbaum A; Garrison J; Kashala O; Chatterjee SK; Bhattacharya-Chatterjee M
    J Clin Oncol; 1999 Sep; 17(9):2889-5. PubMed ID: 10561367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Interest and limits of estimation of the carcinoembryonic antigen in colonic and rectal (author's transl)].
    Arnaud JP; Simon P; Ollier JC; Koehl C; Adloff M
    J Chir (Paris); 1979 Nov; 116(11):633-6. PubMed ID: 555768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.